Infections during tumour necrosis factor- blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients

Authors:
  • LGL. Gossec
    L. Gossec
  • ARA. Ruyssen-Witrand
    A. Ruyssen-Witrand
  • MLM. Luc
    M. Luc
  • MDM. Duclos
    M. Duclos
  • SGS. Guignard
    S. Guignard
  • MDM. Dougados
    M. Dougados

Abstract
Objective. To evaluate the rate of infections in rheumatic patients treated with tumour necrosis factor (TNF)-α blockers in daily practice and to determine potential risk factors of infections.